References
- Staege M S, Lee S P, Frisan T, Mautner J, Scholz S, Pajic A, et al. Myc overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells. Proc Natl Acad Sci USA, 99: 4550–4555
- Cogliatti S B, Novak U, Henz S, Schmid U, Moller P, Barth T F. Swiss Group for Clinical Cancer Research (SAKK). Diagnosis of Burkitt lymphoma in due time: a practical approach. Br J Haematol 2006; 134: 294–301
- Jacobsen E, LaCasce A. Update on the therapy of highly aggressive non-Hodgkin's lymphoma. Expert Opin Biol Ther 2006; 6: 699–708
- Huang Q, Wilczynski S P, Chang K L, Weiss L M. Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces. Am J Clin Pathol 2006; 126: 222–229
- Klebanoff C A, Gattinoni L, Restifo N P. CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev 2006; 211: 214–224
- Paludan C, Bickham K, Nikiforow S, Tsang M L, Goodman K, Hanekom W A, et al. Epstein-Barr nuclear antigen 1-specific CD4(+) Th1 cells kill Burkitt's lymphoma cells. J Immunol 2002; 169: 1593–1603
- Mi J Q, Manches O, Wang J, Perron P, Weisbuch S, Marche P N, et al. Development of autologous cytotoxic CD4 T clones in a human model of B-cell non-Hodgkin follicular lymphoma. Br J Haematol 2006; 135: 324–335
- Haque M A, Ping L, Jackson S K, Zarour H M, Hawes J W, Phan U T, et al. Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes. J Exp Med 2002; l95: 1267–1277
- Pathak S S, Blum J S. Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules. Traffic 2000; 1: 561–569
- Li P, Haque M A, Blum J S. Role of disulfide bonds in regulating antigen processing and epitope selection. J Immunol 2002; 169: 2444–2450
- Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen P M, et al. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 1995; 375: 685–688
- Neves A R, Ensina L F, Anselmo L B, Leite K R, Buzaid A C, Camara-Lopes L H, et al. Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions. Cancer Immunol Immunother 2005; 54: 61–66
- Maggio R, Peragine N, Calabrese E, De Propris M S, Intoppa S, Della Starza I, et al. Generation of functional dendritic cells (DC) in adult acute lymphoblastic leukemia: rationale for a DC-based vaccination program for patients in complete hematological remission. Leuk Lymphoma 2007; 48: 302–310
- Haque M A, Hawes J W, Blum J S. Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition. J Immunol 2001; 166: 4543–4551
- Obermaier B, Dauer M, Herten J, Schad K, Endres S, Eigler A. Development of a new protocol for 2-day generation of mature dendritic cells from human monocytes. Biol Proced Online 2003; 5: 197–203